Ontogenetic  Market Research Report- Forecast till 2027

Ontogenetic Market Information: By Devices (Electroencephalography, Magnetoencephalography), Application (Developmental Biology, Developmental Psychology), End User (Research Laboratories, Academic Institutes, Others) - Forecast till 2027

ID: MRFR/MED/0358-HCR | February 2021 | Region: Global | 75 pages

Ontogenetic Market Scenario


Ontogenetic is a developmental history of an organism, which includes the study of cognitive, physical, social, and emotional development, which can be attributed to experience with the individuals and the environment within the environment. Ontogenetic is a vast subject and continuous research in the field is expanding its applications. Increasing human and animal population is one of the major factors affecting the ontogenetic market growth, positively. Furthermore, increasing funding for research is one of the major driving factors of the ontogenetic market. Epilepsy is the disorder of a nervous system. According to the last updated report on February 2017 by World Health Organization (WHO), around 50 million people are affected with epilepsy globally, and it affects people of all ages. The report suggests that around 2.4 million people are diagnosed with epilepsy every year globally.


Companies are focusing on merger and also collaborating with universities or academic institutes for further study on ontogenetic. In this regards, in March 2016, Natus Medical Incorporated announced its expansion of neurodiagnostic services into seven new states with the acquisition of the assets of NeuroQuest, LLC. This acquisition helped Natus Medical Incorporated in expanding their network globally and helped to increase the market share. Rapidly changing technology plays an important role in the growth of ontogenetic market. Technological advancement is opening new doors to the ontogenetic research and use.


Governments of different nations have done various developments to encourage research, which is driving the ontogenetic market growth. Increasing adoption of various oncologic practices owing to rising patient population having a nervous disorder. According to the last updated report on February 2017 by the World Health Organization (WHO), annually 30-50 cases are diagnosed per 100 000 people, whereas, in low and middle-income countries, this figure is up to two times higher.


The developed countries are holding major ontogenetic market share owing to the availability of advanced infrastructure, skilled professionals, and high expenditure, but the market is rapidly expanding in emerging countries such as India, China, and Brazil. The research activities in Pacific region, especially, in Australia is increasing and is expected to grow significantly during the forecast period.


The Ontogenetic market is expected to grow at a CAGR of 4.2% during the forecast period 2017-2023. 


Intended Audience



  • Ontogenetic Services Providers

  • Hospitals and Clinics

  • Medical Research Laboratories

  • Research and Development Companies

  • Market Research and Consulting Service Providers

  • Potential Investors

  • Government Policy Makers and Authorities 


Figure: Global Ontogenetic Market, By Region Market Share, 2016 (%) Ontogenetic Market


Sources: Annual reports, Press release, White paper, Company presentation 


Segmentations


The ontogenetic market is segmented on the basis of devices, application, and end user.


On the basis of the devices, ontogenetic market is segmented into electroencephalography, magnetoencephalography, and others.


On the basis of the application, ontogenetic market is segmented into developmental biology, developmental psychology, developmental cognitive neuroscience, developmental psychobiology, and others.


On the basis of the end user, ontogenetic market is segmented into research laboratories, academic institutes, and others. Furthermore, the research laboratories are segmented into government research laboratories, independent or private research laboratories, and others.


Regional Analysis


The Americas dominate the ontogenetic market owing to a large amount of money invested in the research and development and clinical trials. The Americas mainly includes North America and South America. North America is the leading regional market, whereas South America ontogenetic market is also growing at a significant rate. The U.S. is the highest revenue generating country within the region.


The European market is the second largest and is expected to grow exponentially during the forecast period. Major European countries like Germany, France, and the U.K are driving ontogenetic market. On the other hand, Eastern European countries are also contributing a major share to this regional market growth. The U.K is expected to grow at a healthy CAGR in the European ontogenetic market.


The Asia Pacific is the fastest growing ontogenetic market owing to increasing funding for research and development and government initiatives to encourage such research. China and Japan are the major players in this region, while India is emerging as the fastest growing country in ontogenetic market.


However, lack of developed infrastructure, low investment in research and development are likely to slow the Middle East & African ontogenetic market growth.  


Key Players


Some of key the players in the ontogenetic market are ANT Neuro (the Netherlands), EMS Handels Gesellschaft mbH (Austria), Natus Medical Incorporated (U.S.), Ontogeny, Inc (U.S.), Symbiotic Devices (Australia), and others.


Research Methodology Global Ontogenetic Market


Sources: Annual reports, Press release, White paper, and Company presentation



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   4.2% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Devices, Application, and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   ANT Neuro (the Netherlands), EMS Handels Gesellschaft mbH (Austria), Natus Medical Incorporated (U.S.), Ontogeny, Inc (U.S.), Symbiotic Devices (Australia), and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing human and animal population
  • Increasing funding for research


  • Speak to Analyst Ask for Customization

    Table of Content


    Report Prologue

    Market Introduction


    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations


    Research Methodology


    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation


    Market Dynamics


    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment


    Market Factor Analysis


    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis


    Global Ontogenetic Market, by Devices


    6.1 Introduction

    6.2 Electro encephalography

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 Magneto encephalography

    6.3.1 Market Estimates & Forecast, 2020-2027

    6.4 Others

    6.4.1 Market Estimates & Forecast, 2020-2027


    Global Ontogenetic Market, by Application


    7.1 Introduction

    7.2 Developmental Biology

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 Developmental Psychology

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Developmental Cognitive Neuroscience

    7.4.1 Market Estimates & Forecast, 2020-2027

    7.5 Developmental psychobiology

    7.5.1 Market Estimates & Forecast, 2020-2027

    7.6 Others

    7.6.1 Market Estimates & Forecast, 2020-2027


    Global Ontogenetic Market, by End User


    8.1 Introduction

    8.2 Research laboratories

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Academic Institutes

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Others

    8.4.1 Market Estimates & Forecast, 2020-2027


    Global Ontogenetic Market, by Region


    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 U.S.

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 U.K.

    9.3.1.4 Italy

    9.3.1.5 Spain

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic of Korea

    9.4.6 Rest of Asia Pacific

    9.5 The Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest of the Middle East & Africa

    10 Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    11 Company Profiles

    11.1 ANT Neuro

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials

    11.1.4 SWOT Analysis

    11.2 Core Tech Solutions Inc

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 EMS Handels Gesellschaft mbH

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Natus Medical Incorporated

    11.4.1 Company Overview

    11.4.2 Product/Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Ontogeny, Inc

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.6 Symbiotic Devices

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.7 Others

    12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Prediction of Pharmaceutical Industry

    13 Appendix




    LIST OF TABLES

    Table 1 Ontogenetic Industry Synopsis, 2020-2027

    Table 2 Global Ontogenetic Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Ontogenetic Market by Region, 2020-2027, (USD Million)

    Table 4 Global Ontogenetic Market by Devices, 2020-2027, (USD Million)

    Table 5 Global Ontogenetic Market by Application, 2020-2027, (USD Million)

    Table 6 Global Ontogenetic Market by End Users, 2020-2027, (USD Million)

    Table 7 North America Ontogenetic Market by Devices, 2020-2027, (USD Million)

    Table 8 North America Ontogenetic Market by Application, 2020-2027, (USD Million)

    Table 9 North America Ontogenetic Market by End Users, 2020-2027, (USD Million)

    Table 10 US Ontogenetic Market by Devices, 2020-2027, (USD Million)

    Table 11 US Ontogenetic Market by Application, 2020-2027, (USD Million)

    Table 12 US Ontogenetic Market by End Users, 2020-2027, (USD Million)

    Table 13 Canada Ontogenetic Market by Devices, 2020-2027, (USD Million)

    Table 14 Canada Ontogenetic Market by Application, 2020-2027, (USD Million)

    Table 15 Canada Ontogenetic Market by End Users, 2020-2027, (USD Million)

    Table 16 South America Ontogenetic Market by Devices, 2020-2027, (USD Million)

    Table 17 South America Ontogenetic Market by Application, 2020-2027, (USD Million)

    Table 18 South America Ontogenetic Market by End Users, 2020-2027, (USD Million)

    Table 19 Europe Ontogenetic Market by Devices, 2020-2027, (USD Million)

    Table 20 Europe Ontogenetic Market by Application, 2020-2027, (USD Million)

    Table 21 Europe Ontogenetic Market by End Users, 2020-2027, (USD Million)

    Table 22 Western Europe Ontogenetic Market by Devices, 2020-2027, (USD Million)

    Table 23 Western Europe Ontogenetic Market by Application, 2020-2027, (USD Million)

    Table 24 Western Europe Ontogenetic Market by End Users, 2020-2027, (USD Million)

    Table 25 Eastern Europe Ontogenetic Market by Devices, 2020-2027, (USD Million)

    Table 26 Eastern Europe Ontogenetic Market by Application, 2020-2027, (USD Million)

    Table 27 Eastern Europe Ontogenetic Market by End Users, 2020-2027, (USD Million)

    Table 28 Asia Pacific Ontogenetic Market by Devices, 2020-2027, (USD Million)

    Table 29 Asia Pacific Ontogenetic Market by Application, 2020-2027, (USD Million)

    Table 30 Asia Pacific Ontogenetic Market by End Users, 2020-2027, (USD Million)

    Table 31 Middle East & Africa Ontogenetic Market by Devices, 2020-2027, (USD Million)

    Table 32 Middle East & Africa Ontogenetic Market by Application, 2020-2027, (USD Million)

    Table 33 Middle East & Africa Ontogenetic Market by End Users, 2020-2027, (USD Million)



    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Ontogenetic Market

    Figure 3 Segmentation Market Dynamics for Ontogenetic Market

    Figure 4 Global Ontogenetic Market Share, by Devices 2020

    Figure 5 Global Ontogenetic Market Share, by Application 2020

    Figure 6 Global Ontogenetic Market Share, by End Users, 2020

    Figure 7 Global Ontogenetic Market Share, by Region, 2020

    Figure 8 America Ontogenetic Market Share, by Country, 2020

    Figure 9 Europe Ontogenetic Market Share, by Country, 2020

    Figure 10 Asia Pacific Ontogenetic Market Share, by Country, 2020

    Figure 11 Middle East & Africa Ontogenetic Market Share, by Country, 2020

    Figure 12 Global Ontogenetic Market: Company Share Analysis, 2020 (%)

    Figure 13 ANT Neuro: Key Financials

    Figure 14 ANT Neuro: Segmental Revenue

    Figure 15 ANT Neuro: Geographical Revenue

    Figure 16 Core Tech Solutions Inc: Key Financials

    Figure 17 Core Tech Solutions Inc: Segmental Revenue

    Figure 18 Core Tech Solutions Inc: Geographical Revenue

    Figure 19 EMS Handels Gesellschaft mbH: Key Financials

    Figure 20 EMS Handels Gesellschaft mbH: Segmental Revenue

    Figure 21 EMS Handels Gesellschaft mbH: Geographical Revenue

    Figure 22 Natus Medical Incorporated: Key Financials

    Figure 23 Natus Medical Incorporated: Segmental Revenue

    Figure 24 Natus Medical Incorporated: Geographical Revenue

    Figure 25 Ontogeny, Inc: Key Financials

    Figure 26 Ontogeny, Inc: Segmental Revenue

    Figure 27 Ontogeny, Inc: Geographical Revenue

    Figure 28 Symbiotic Devices: Key Financials

    Figure 29 Symbiotic Devices: Segmental Revenue

    Figure 30 Symbiotic Devices: Geographical Revenue